In the present cohort, 39.4% of thyroid cancers with these high‐risk mutations were detected, including five cases of BRAF V600E mutation (one combined with TERT mutation), two cases of TERT mutations and seven gene fusions. This evidence concerns the gene BRAF and thyroid cancer.